Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

What's NEXT for CML-NGS mutation screening.

Blood - 20 Feb 2020

Shanmuganathan Naranie, Hughes Timothy P

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Mutation

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 32078686
DOI: 10.1182/blood.2019004559

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

What's NEXT for CML-NGS mutation screening.PMID 32078686Read ↗

Non-Ph variants in CML: guilty drivers?Semantic proximity Read ↗

Can We Use Targeted Next-Generation Sequencing an Alternative Method to the Conventional Tests in Haematological Malignancies?Semantic proximity Read ↗

Your DNA is not your diagnosis: getting diagnoses right following secondary genomic findings.Semantic proximity Read ↗

Next-generation sequencing for measuring minimal residual disease in AML.Semantic proximity Read ↗

Next‐generation sequencing – feasibility and practicality in haematologySemantic proximity Read ↗

Do next-generation sequencing results drive diagnostic and therapeutic decisions in MDS?Semantic proximity Read ↗

Molecular Testing in CML between Old and New Methods: Are We at a Turning Point?Semantic proximity Read ↗

IDH mutation testing in gliomas-where do we draw the line?Semantic proximity Read ↗

Targeting IDH: the next big thing in AML.Semantic proximity Read ↗

Targeted next-generation sequencing detects point mutations, insertions, deletions and balanced chromosomal rearrangements as well as identifies novel leukemia-specific fusion genes in a single procedureSemantic proximity Read ↗

Is it the time to integrate novel sequencing technologies into clinical practice?Semantic proximity Read ↗

Recurrent mutations and targeted therapy in FL.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.